Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Cell

• Publication date

  1991-06-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0092-8674(91)90007-LPMID 1648447
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activation of Epstein–Barr virus latent genes protects human B cells from death by apoptosis

  1991cited by this paper
• Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man

  1991cited by this paper
• Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2

  1990cited by this paper
• Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

  1990cited by this paper
• Epstein–Barr virus latent membrane protein inhibits human epithelial cell differentiation

  1990cited by this paper
• The pathogenesis of Burkitt's lymphoma.

  1990cited by this paper
• Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.

  1990cited by this paper
• Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis

  1990cited by this paper
• Morphological transformation of human keratinocytes expressing the LMP gene of Epstein Barr virus

  1990cited by this paper
• Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

  1990cited by this paper
• Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.

  1990cited by this paper
• A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1

  1990cited by this paper
• Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23

  1990cited by this paper
• Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures

  1989cited by this paper
• Mechanism of antigen-driven selection in germinal centres

  1989cited by this paper
• Epstein‐barr virus‐infected b cells persist in the circulation of acyclovir‐treated virus carriers

  1989cited by this paper
• Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immortalized B cells.

  1989cited by this paper
• bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.

  1989cited by this paper
• The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation

  1989cited by this paper
• Deregulated BCL2 expression enhances growth of a human B cell line.

  1989cited by this paper
• Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells.

  1989cited by this paper
• Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.

  1989cited by this paper
• Eradication of Epstein-Barr virus by allogeneic bone marrow transplantation: implications for sites of viral latency.

  1988cited by this paper
• Downregulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein- Barr virus-positive Burkitt's lymphoma underlies tumor cell escape from virus-specific T cell surveillance

  1988cited by this paper
• 2,3,7,8-Tetrachlorodibenzo-p-dioxin kills immature thymocytes by Ca2+-mediated endonuclease activation.

  1988cited by this paper
• Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity

  1988cited by this paper
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

  1988cited by this paper
• Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.

  1987cited by this paper
• Differences in B cell growth phenotype reflect novel patterns of Epstein‐Barr virus latent gene expression in Burkitt's lymphoma cells.

  1987cited by this paper
• Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation.

  1987cited by this paper
• Monoclonal antibodies to the latent membrane protein of Epstein-Barr virus reveal heterogeneity of the protein and inducible expression in virus-transformed cells.

  1987cited by this paper
• Death and the cell.

  1986cited by this paper
• Antigen‐Driven Selection of Virgin and Memory B Cells

  1986cited by this paper
• Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation.

  1986cited by this paper
• Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma.

  1986cited by this paper
• fgr proto-oncogene mRNA induced in B lymphocytes by Epstein–Barr virus infection

  1986cited by this paper
• Endemic Burkitt's lymphoma: phenotypic analysis of tumor biopsy cells and of derived tumor cell lines.

  1986cited by this paper
• Epstein‐Barr virus status and tumour cell phenotype in sporadic Burkitt's lymphoma

  1986cited by this paper
• Early events in Epstein-Barr virus infection provide a model for B cell activation

  1985cited by this paper
• Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.

  1985cited by this paper
• Distinctions between endemic and sporadic forms of epstein‐barr virus‐positive burkitt's lymphoma

  1985cited by this paper
• Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

  1985cited by this paper
• An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.

  1985cited by this paper
• Chromatin cleavage in apoptosis: Association with condensed chromatin morphology and dependence on macromolecular synthesis

  1984cited by this paper
• A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells.

  1984cited by this paper
• Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation.

  1984cited by this paper
• Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation

  1980cited by this paper
• The Virus as the Etiologic Agent of Infectious Mononucleosis

  1979cited by this paper
• The establishment of lymphoblastoid lines from adult and fetal human lymphoid tissue and its dependence on EBV

  1971cited by this paper

• Inhibition of death-ligand-induced apoptosis in Epstein-Barr virus-encoded small RNAs-expressing human T-cell line.

  2026cites this paper
• The EBV-MS paradigm: beyond molecular mimicry toward new therapeutic strategies.

  2026cites this paper
• A thorough insight into the life cycle of the Epstein-Barr virus. From the molecular to the organismal level

  2025cites this paper
• The Epstein-Barr Virus in Classical Hodgkin Lymphoma: Pathogenesis, Immunobiology, and Therapeutic Implications.

  2025cites this paper
• Harnessing Cellular Immunotherapy for EBV‐Associated Malignancies: Current Advances and Future Directions

  2025cites this paper
• A Review of Mitochondrial Involvement in Cell Death Pathways Induced by Oncogenic Viruses

  2025cites this paper
• Oncogenic Potential of Epstein‐Barr Virus in NK and NKT Cells Contribute to the Rapid Deterioration of Hemophagocytic Lymphohistiocytosis

  2025cites this paper
• Delving deeper into the pathogenesis and genomics of posttransplant diffuse large B‐cell lymphoma

  2025influential citation
• The Latent Membrane Protein 1 (LMP1): Biological Functions and Molecular Mechanisms.

  2025cites this paper
• Epstein–Barr virus and nasopharyngeal carcinoma: сurrent view at the problem. Part 1. Epstein–Barr virus and its properties

  2025cites this paper
• Tumor‐Associated Sympathetic Nerves Promote the Progression of Epstein‐Barr Virus‐Positive Diffuse Large B‐Cell Lymphoma

  2025cites this paper
• Clinicopathologic Insights and Molecular Oncogenesis: Understanding Epstein-Barr Virus-Induced B-cell Lymphoproliferations

  2024cites this paper
• Combination of bortezomib and venetoclax targets the pro-survival function of LMP-1 and EBNA-3C of Epstein-Barr virus in spontaneous lymphoblastoid cell lines

  2024cites this paper
• The role of Epstein-Barr virus in autoimmune and autoinflammatory diseases

  2024cites this paper
• Epstein-Barr virus lytic gene BNRF1 promotes B-cell lymphomagenesis via IFI27 upregulation

  2024cites this paper
• Epstein-Barr virus-encoded Latent Membrane protein-1(LMP-1) as a Prognostic marker in OSCC and OPMDs

  2024cites this paper
• Assembly and activation of EBV latent membrane protein 1.

  2024cites this paper
• Recent Advances in Assessing the Clinical Implications of Epstein-Barr Virus Infection and Their Application to the Diagnosis and Treatment of Nasopharyngeal Carcinoma

  2023cites this paper
• Post‐transplant lymphoproliferative disorder: Update on treatment and novel therapies

  2023cites this paper
• Advancing therapeutic strategies for Epstein-Barr virus-associated malignancies through lytic reactivation.

  2023cites this paper
• Targeting Cyclin‐Dependent Kinase 1 Induces Apoptosis and Cell Cycle Arrest of Activated Hepatic Stellate Cells

  2023cites this paper
• Pre-Emptive Use of Rituximab in Epstein–Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes

  2023cites this paper
• Pathophysiology of Hodgkin’s Lymphoma and Role of Immune System

  2022cites this paper
• Time-resolved transcriptomes reveal diverse B cell fate trajectories in the early response to Epstein-Barr virus infection.

  2022cites this paper
• EBV-associated diseases: Current therapeutics and emerging technologies

  2022cites this paper
• Shaping the host cell environment with viral noncoding RNAs.

  2022cites this paper
• Fate-resolved gene regulatory signatures of individual B lymphocytes in the early stages of Epstein-Barr Virus infection

  2022cites this paper
• Therapeutics targeting BCL2 family proteins

  2022cites this paper
• Are Viral Infections Key Inducers of Autoimmune Diseases? Focus on Epstein–Barr Virus

  2022cites this paper
• Integrative Transcriptomics and Proteomics Analysis Provide a Deep Insight Into Bovine Viral Diarrhea Virus-Host Interactions During BVDV Infection

  2022cites this paper
• The role of Epstein–Barr virus-encoded latent membrane proteins in host immune escape

  2021cites this paper
• Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases

  2021cites this paper
• Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer

  2021cites this paper
• Relationship between BCL-2 Oncogene Expression and Apoptosis in a Human Leukemia T Cell Line

  2021cites this paper
• Calcium-dependent signalling in B-cell lymphomas

  2021cites this paper
• The contribution of ebv to the pathogenesis of classical hodgkin lymphoma

  2021cites this paper
• A Systematic Review of the Potential Implication of Infectious Agents in Myasthenia Gravis

  2021cites this paper
• 全血EB病毒DNA载量对异基因造血干细胞移植后淋巴增殖性疾病的诊断价值

  2021cites this paper
• The potential of proliferative and apoptotic parameters in clinical flow cytometry of myeloid malignancies.

  2021cites this paper
• Classic Hodgkin Lymphoma - Old Disease, New Directions: An Update on Pathology, Molecular Features and Biological Prognostic Markers.

  2021cites this paper
• Anoikis Resistance and Development in Prostate Cancer: The Possible Role of HPV/EBV Coinfection

  2021cites this paper
• Lymphoepithelial Carcinoma of Salivary Glands.

  2021cites this paper
• General Principles of Ophthalmic Pathology

  2021cites this paper
• Epstein-Barr Virus as the Cause of Rheumatoid Arthritis

  2021cites this paper
• EBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape

  2020cites this paper
• A Review on Apoptosis: When Death Precedes Life

  2020cites this paper
• Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection

  2020cites this paper
• Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation

  2020cites this paper
• BCL-XL inhibition by BH3-mimetic drugs induces apoptosis in models of Epstein-Barr virus-associated T/NK-cell lymphoma.

  2020cites this paper
• The BCL‐2 family protein inhibitor ABT‐737 as an additional tool for the treatment of EBV‐associated post‐transplant lymphoproliferative disorders

  2020cites this paper
• Up-Regulated Genes in Cell Cycle Pathway of ccRCC Discovered by High-Throughput Sequencing Data Mining

  2020cites this paper
• The involvement of regulated cell death forms in modulating the bacterial and viral pathogenesis

  2020cites this paper
• Targeted Therapies for Epstein-Barr Virus-Associated Lymphomas

  2020cites this paper
• The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence

  2019cites this paper
• EBV LMP1 in Gingival Epithelium Potentially Contributes to Human Chronic Periodontitis via Inducible IL8 Production

  2019cites this paper
• EBV-Associated Lymphoproliferative Disorders: Update in Classification.

  2019cites this paper
• Dysregulation of Cell Survival in Diffuse Large B Cell Lymphoma: Mechanisms and Therapeutic Targets

  2019cites this paper
• Mitochondrial Heat Shock Response Induced by Ectromelia Virus is Accompanied by Reduced Apoptotic Potential in Murine L929 Fibroblasts

  2019cites this paper
• Epstein-Barr virus-related post-transplant lymphoproliferative disease (EBV-PTLD) in the setting of allogeneic stem cell transplantation: a comprehensive review from pathogenesis to forthcoming treatment modalities

  2019cites this paper
• First phase insulin response in children with islet autoantibodies : results from the Finnish Type 1 Diabetes Prediction and Prevention study

  2019cites this paper
• An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma.

  2019cites this paper
• Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders

  2019cites this paper
• Precision Molecular Pathology of Hodgkin Lymphoma

  2018cites this paper
• Management of post‐transplant lymphoproliferative disorders

  2018cites this paper
• Epstein-Barr virus encoded latent membrane protein 1 suppresses necroptosis through targeting RIPK1/3 ubiquitination

  2018cites this paper
• The development of a novel S/MAR DNA vector platform for the stable, persistent and safe genetic engineering of dividing cells

  2018cites this paper
• Role of EBV in Classical Hodgkin Lymphoma

  2018cites this paper
• Epstein Barr Virus genome variation and functional analysis of the IR-1 internal repeat

  2018cites this paper
• Contribution of tumour cell signalling and the microenvironment to the pathogenesis of EBV-associated B cell lymphoma and

  2018cites this paper
• CD21-independent Epstein-Barr virus entry into NK cells.

  2018cites this paper
• Epstein-Barr virus (EBV)-associated lymphoid proliferations, a 2018 update.

  2018cites this paper
• Understanding the Role of Epstein - Barr virus Encoded RNAs (EBERs) in EBV Biology

  2018influential citation
• Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma

  2018cites this paper
• Expression: Relationship to Resistance to Leads to Down-Regulation of Bim EBV Infection of Human B Lymphocytes

  2017cites this paper
• Epstein-Barr virus in tumor-infiltrating B cells of myasthenia gravis thymoma: an innocent bystander or an autoimmunity mediator?

  2017cites this paper
• lbxoPlasma gondii Inhibits the in vitro induced Apoptosis of HL-60 Cells

  2017cites this paper
• Tumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1

  2017cites this paper
• Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection

  2017cites this paper
• Epstein–Barr virus (EBV)-associated epithelial and non-epithelial lesions of the oral cavity

  2017cites this paper
• EBV and Apoptosis: The Viral Master Regulator of Cell Fate?

  2017cites this paper
• Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type

  2017cites this paper
• CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors.

  2017influential citation
• Defects in the Proximal Fas Signaling EBV-Infected B Cell Lymphomas Is Due to Resistance to Fas-Mediated Apoptosis in

  2017cites this paper
• Syndrome mononucléosique et pathologies hématologiques liées au virus d’Epstein-Barr

  2017cites this paper
• Effects of Merkel cell polyomavirus T antigen expression on cell transformation of Merkel cells

  2016cites this paper
• Molecular insights into host gene regulation by Epstein-Barr virus nuclear antigen EBNA3C

  2016influential citation
• A Comparative Review on the Three Variants of Burkitt Lymphoma

  2016cites this paper
• Understanding the role of Epstein-Barr virus in T- and NK-cell disorders

  2016influential citation
• Development of MHC class II-restricted TCR gene therapy for Epstein Barr virus associated malignancies

  2016cites this paper
• Transformation of follicular lymphoma into classical Hodgkin lymphoma showing t(14;18)

  2016cites this paper
• Photodynamic Therapy : New Light to the Nasopharyngeal Carcinoma Treatment

  2016cites this paper
• Cancer Hallmarks, Biomarkers and Breast Cancer Molecular Subtypes

  2016cites this paper
• [Infectious and neoplasic complications after kidney transplantation].

  2016cites this paper
• Post-transplant Lymphoproliferative Disorder (PTLD): Infection, Cancer?

  2016cites this paper
• Integrative genomic and proteomic analyses identifies glycerol-3-phosphate acyltransferase as a target of low-dose ionizing radiation in EBV infected-B cells

  2016cites this paper
• Article Open Access

  2015cites this paper
• EBV Persistence--Introducing the Virus.

  2015cites this paper
• Contribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma.

  2015cites this paper
• BH3 Profiling Reveals Selectivity by Herpesviruses for Specific Bcl-2 Proteins To Mediate Survival of Latently Infected Cells

  2015cites this paper
• The Latent Membrane Protein 1 (LMP1).

  2015cites this paper